推进跨性别与性别多元癌症患者的公平肿瘤生育照护
本文为叙述性综述,关注跨性别与性别多元(TGD)癌症患者的生育力保存问题。文章梳理了性别肯定激素治疗对性腺功能的影响、生育力保存选项的选择依据,以及TGD人群在费用、咨询、提供者专业度、歧视与可及性方面的障碍,并指出咨询、临床实践、研究与政策方面的关键缺口。
要点
- TGD癌症患者生育力保存面临交叉性挑战,专业学会推荐早期生育咨询但证据有限。
- 性别肯定激素治疗可能影响性腺功能与配子发生,中断激素治疗可能加重性别烦躁。
- 生育力保存选择取决于生殖解剖、青春期状态、既往治疗及肿瘤学考量。
核心结论
- 改善TGD癌症患者生育照护需要早期个体化咨询、多学科协作、公平可及的服务、纵向生殖结局研究及包容性临床环境。
研究设计与样本
- 叙述性综述,聚焦TGD患者(尤其癌症患者)的生育与生育力保存现有证据。
主要发现
- 性别肯定激素治疗可能影响性腺功能与配子发生。
- 中断激素治疗以进行生育力保存可能加重性别烦躁。
- 生育力保存选项包括卵母细胞、胚胎、精子、卵巢组织及睾丸组织冷冻保存。
- TGD患者面临费用、咨询不足、提供者专业度不够、歧视或偏见及生育照护可及性缺乏等障碍。
关键数值与推荐
- 专业学会推荐对癌症患者及接受性别肯定治疗者进行早期生育咨询。
临床怎么用
- 对TGD癌症患者应早期提供个体化生育咨询并开展多学科协作。
- 生育力保存方案选择需综合生殖解剖、青春期状态、既往治疗及肿瘤学考量。
- 应创建包容性临床环境以支持患者完成生育力保存与癌症照护。
局限性
- 针对TGD人群肿瘤生育的专门证据仍然有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Transgender and gender-diverse (TGD) patients with cancer face unique and intersecting challenges related to fertility preservation. Although professional societies recommend early fertility counseling for both patients with cancer and individuals undergoing gender-affirming treatment, evidence specifically addressing oncofertility in TGD populations remains limited. Gender-affirming hormone therapy may affect gonadal function and gametogenesis, whereas interruption of hormone therapy for fertility preservation may exacerbate gender dysphoria. Fertility preservation options include oocyte, embryo, sperm, ovarian tissue, and testicular tissue cryopreservation, with selection dependent on reproductive anatomy, pubertal status, prior treatment, and oncologic considerations. Transgender and gender-diverse patients also face substantial barriers to fertility preservation, including cost, inadequate counseling, insufficient provider expertise, discrimination or bias, and lack of access to fertility care. This narrative review examines current evidence regarding fertility and fertility preservation in TGD patients, with particular attention to patients with cancer, and identifies critical gaps in counseling, clinical practice, research, and policy. Improving care will require early and individualized counseling, multidisciplinary collaboration, equitable access to these services, longitudinal research addressing reproductive outcomes in TGD cancer survivors, and the creation of inclusive clinical environments that support patients throughout fertility preservation and cancer care.
引用
- Coyne K, Visvabharathy V, Daunov K, et al. Advancing equitable oncofertility care for transgender and gender-diverse patients. Fertil Steril. 2026. PMID: 42863744. doi:10.1016/j.fertnstert.2026.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。